Single User License
INR 102255
Site License
INR 204510
Corporate User License
INR 306765

Service Tax Additional

select a format
Price

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Arena Pharmaceuticals, Inc.-Product Pipeline Review-2015

Arena Pharmaceuticals, Inc.-Product Pipeline Review-2015


  Request for Sample Report

Executive Summary

Arena Pharmaceuticals, Inc.-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'Arena Pharmaceuticals, Inc.-Product Pipeline Review-2015', provides an overview of the Arena Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Arena Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Arena Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Arena Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Arena Pharmaceuticals, Inc.'s pipeline products

Reasons To Buy

Evaluate Arena Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Arena Pharmaceuticals, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Arena Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Arena Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Arena Pharmaceuticals, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Arena Pharmaceuticals, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Arena Pharmaceuticals, Inc. Snapshot 5

Arena Pharmaceuticals, Inc. Overview 5

Key Information 5

Key Facts 5

Arena Pharmaceuticals, Inc.-Research and Development Overview 6

Key Therapeutic Areas 6

Arena Pharmaceuticals, Inc.-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Pipeline Products-Partnered Products 10

Partnered Products/Combination Treatment Modalities 11

Pipeline Products-Out-Licensed Products 12

Out-Licensed Products/Combination Treatment Modalities 13

Arena Pharmaceuticals, Inc.-Pipeline Products Glance 14

Arena Pharmaceuticals, Inc.-Late Stage Pipeline Products 14

Pre-Registration Products/Combination Treatment Modalities 14

Filing rejected/Withdrawn Products/Combination Treatment Modalities 15

Arena Pharmaceuticals, Inc.-Clinical Stage Pipeline Products 16

Phase II Products/Combination Treatment Modalities 16

Phase I Products/Combination Treatment Modalities 17

Arena Pharmaceuticals, Inc.-Drug Profiles 18

lorcaserin hydrochloride 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

ralinepag 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

APD-334 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

APD-371 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

temanogrel hydrochloride 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

Arena Pharmaceuticals, Inc.-Pipeline Analysis 27

Arena Pharmaceuticals, Inc.-Pipeline Products by Target 27

Arena Pharmaceuticals, Inc.-Pipeline Products by Route of Administration 28

Arena Pharmaceuticals, Inc.-Pipeline Products by Molecule Type 29

Arena Pharmaceuticals, Inc.-Pipeline Products by Mechanism of Action 30

Arena Pharmaceuticals, Inc.-Recent Pipeline Updates 31

Arena Pharmaceuticals, Inc.-Dormant Projects 40

Arena Pharmaceuticals, Inc.-Discontinued Pipeline Products 41

Discontinued Pipeline Product Profiles 41

APD-597 41

nelotanserin 41

Arena Pharmaceuticals, Inc.-Company Statement 42

Arena Pharmaceuticals, Inc.-Locations And Subsidiaries 46

Head Office 46

Other Locations & Subsidiaries 46

Appendix 47

Methodology 47

Coverage 47

Secondary Research 47

Primary Research 47

Expert Panel Validation 47

Contact Us 47

Disclaimer 48

List of Tables

Arena Pharmaceuticals, Inc., Key Information 5

Arena Pharmaceuticals, Inc., Key Facts 5

Arena Pharmaceuticals, Inc.-Pipeline by Indication, 2015 7

Arena Pharmaceuticals, Inc.-Pipeline by Stage of Development, 2015 8

Arena Pharmaceuticals, Inc.-Monotherapy Products in Pipeline, 2015 9

Arena Pharmaceuticals, Inc.-Partnered Products in Pipeline, 2015 10

Arena Pharmaceuticals, Inc.-Partnered Products/ Combination Treatment Modalities, 2015 11

Arena Pharmaceuticals, Inc.-Out-Licensed Products in Pipeline, 2015 12

Arena Pharmaceuticals, Inc.-Out-Licensed Products/ Combination Treatment Modalities, 2015 13

Arena Pharmaceuticals, Inc.-Pre-Registration, 2015 14

Arena Pharmaceuticals, Inc.-Filing rejected/Withdrawn, 2015 15

Arena Pharmaceuticals, Inc.-Phase II, 2015 16

Arena Pharmaceuticals, Inc.-Phase I, 2015 17

Arena Pharmaceuticals, Inc.-Pipeline by Target, 2015 27

Arena Pharmaceuticals, Inc.-Pipeline by Route of Administration, 2015 28

Arena Pharmaceuticals, Inc.-Pipeline by Molecule Type, 2015 29

Arena Pharmaceuticals, Inc.-Pipeline Products by Mechanism of Action, 2015 30

Arena Pharmaceuticals, Inc.-Recent Pipeline Updates, 2015 31

Arena Pharmaceuticals, Inc.-Dormant Developmental Projects,2015 40

Arena Pharmaceuticals, Inc.-Discontinued Pipeline Products, 2015 41

Arena Pharmaceuticals, Inc., Subsidiaries 46

List of Figures

Arena Pharmaceuticals, Inc.-Pipeline by Top 10 Indication, 2015 7

Arena Pharmaceuticals, Inc.-Pipeline by Stage of Development, 2015 8

Arena Pharmaceuticals, Inc.-Monotherapy Products in Pipeline, 2015 9

Arena Pharmaceuticals, Inc.-Pipeline by Top 10 Target, 2015 27

Arena Pharmaceuticals, Inc.-Pipeline by Top 10 Route of Administration, 2015 28

Arena Pharmaceuticals, Inc.-Pipeline by Top 10 Molecule Type, 2015 29

Arena Pharmaceuticals, Inc.-Pipeline Products by Top 10 Mechanism of Action, 2015 30

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Arena Pharmaceuticals, Inc.; Arena Pharmaceuticals, Inc. - Key Therapeutics; Arena Pharmaceuticals, Inc. - Pipeline Overview and Promising Molecules; Arena Pharmaceuticals, Inc. - News; Arena Pharmaceuticals, Inc. - Latest Updates; Arena Pharmaceuticals, Inc. - Pipeline; Arena Pharmaceuticals, Inc. - Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com